国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Macaca fascicularis Actin-like protein 7B (ACTL7B) CSB-YP846490MOV
CSB-EP846490MOV
CSB-BP846490MOV
CSB-MP846490MOV
CSB-EP846490MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Zinc transporter ZIP9 (SLC39A9), partial CSB-YP846491MOV1
CSB-EP846491MOV1
CSB-BP846491MOV1
CSB-MP846491MOV1
CSB-EP846491MOV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Coiled-coil domain-containing protein 110 (CCDC110), partial CSB-YP846492MOV
CSB-EP846492MOV
CSB-BP846492MOV
CSB-MP846492MOV
CSB-EP846492MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis DEP domain-containing protein 7 (DEPDC7), partial CSB-YP846493MOV
CSB-EP846493MOV
CSB-BP846493MOV
CSB-MP846493MOV
CSB-EP846493MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Dynein assembly factor 3, axonemal (DNAAF3), partial CSB-YP846494MOV
CSB-EP846494MOV
CSB-BP846494MOV
CSB-MP846494MOV
CSB-EP846494MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Nuclear receptor subfamily 2 group C member 1 (NR2C1), partial CSB-YP846495MOV
CSB-EP846495MOV
CSB-BP846495MOV
CSB-MP846495MOV
CSB-EP846495MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis FAST kinase domain-containing protein 5 (FASTKD5), partial CSB-YP846496MOV
CSB-EP846496MOV
CSB-BP846496MOV
CSB-MP846496MOV
CSB-EP846496MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis MANSC domain-containing protein 1 (MANSC1), partial CSB-YP846497MOV
CSB-EP846497MOV
CSB-BP846497MOV
CSB-MP846497MOV
CSB-EP846497MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rabbit Arginase-1 (ARG1) CSB-YP846498RB
CSB-EP846498RB
CSB-BP846498RB
CSB-MP846498RB
CSB-EP846498RB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine NF-kappa-B essential modulator (IKBKG) CSB-YP846499BO
CSB-EP846499BO
CSB-BP846499BO
CSB-MP846499BO
CSB-EP846499BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig Fibroblast growth factor 9 (FGF9) CSB-YP846500PI
CSB-EP846500PI
CSB-BP846500PI
CSB-MP846500PI
CSB-EP846500PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macropus eugenii Steroidogenic factor 1 (NR5A1) CSB-YP846501MPE
CSB-EP846501MPE
CSB-BP846501MPE
CSB-MP846501MPE
CSB-EP846501MPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca nemestrina CD209 antigen (CD209), partial CSB-YP846502MOX
CSB-EP846502MOX
CSB-BP846502MOX
CSB-MP846502MOX
CSB-EP846502MOX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gorilla gorilla gorilla Duffy antigen/chemokine receptor (DARC), partial CSB-YP846503GGZ1
CSB-EP846503GGZ1
CSB-BP846503GGZ1
CSB-MP846503GGZ1
CSB-EP846503GGZ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Zinc finger Y-chromosomal protein (ZFY), partial CSB-YP846504BO
CSB-EP846504BO
CSB-BP846504BO
CSB-MP846504BO
CSB-EP846504BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis TBC1 domain family member 22B (TBC1D22B), partial CSB-YP846505MOV
CSB-EP846505MOV
CSB-BP846505MOV
CSB-MP846505MOV
CSB-EP846505MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (PPP2R2C) CSB-YP846506MOV
CSB-EP846506MOV
CSB-BP846506MOV
CSB-MP846506MOV
CSB-EP846506MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Coiled-coil domain-containing protein 96 (CCDC96), partial CSB-YP846507MOV
CSB-EP846507MOV
CSB-BP846507MOV
CSB-MP846507MOV
CSB-EP846507MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca fascicularis Fibrous sheath-interacting protein 1 (FSIP1), partial CSB-YP846508MOV
CSB-EP846508MOV
CSB-BP846508MOV
CSB-MP846508MOV
CSB-EP846508MOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca mulatta Liver-expressed antimicrobial peptide 2 (LEAP2) CSB-YP846509MOW
CSB-EP846509MOW
CSB-BP846509MOW
CSB-MP846509MOW
CSB-EP846509MOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>